Seronegative myasthenia gravis and Graves' disease. Is there a link?

Exp Clin Endocrinol Diabetes. 2012 May;120(5):254-6. doi: 10.1055/s-0032-1304598. Epub 2012 Mar 15.

Abstract

Graves' disease (GD) and myasthenia gravis (MG) are common autoimmune diseases but their coexistence is very rare. They may possibly share the same pathogenetic mechanisms. Recent research has shown the involvement of autoantibodies, lymphocytes, cytokines and chemokines in the pathogenesis of MG and GD. It appears that Th17 cell lineage is involved in autoimmune thyroid disease (AITD) and seems to be key factor in the development of both MG and GD.A 34-year-old male with seronegative myasthenia gravis due to thymic hyperplasia was diagnosed with also GD and opthalmopathy. Several diagnostic and therapeutic issues regarding the relevant literature are discussed.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Graves Disease / complications*
  • Graves Disease / drug therapy
  • Graves Disease / immunology
  • Histocytochemistry
  • Humans
  • Male
  • Myasthenia Gravis / complications*
  • Myasthenia Gravis / drug therapy
  • Myasthenia Gravis / immunology
  • Peptides, Cyclic / therapeutic use
  • Somatostatin / analogs & derivatives
  • Somatostatin / therapeutic use
  • Thymectomy
  • Thymus Hyperplasia / complications*
  • Thymus Hyperplasia / drug therapy
  • Thymus Hyperplasia / immunology
  • Thyroid Hormones / blood

Substances

  • Peptides, Cyclic
  • Thyroid Hormones
  • lanreotide
  • Somatostatin